This disclosure provides a system for producing pancreatic islet cells
from embryonic stem cells. Differentiation is initiated towards endoderm
cells, and focused using reagents that promote emergence of islet
precursors and mature insulin-secreting cells. High quality populations
of islet cells can be produced in commercial quantities for use in
research, drug screening, or regenerative medicine.